Skip to main content

Advertisement

Table 1 The clinic- pathological features of patients with pituitary adenoma

From: Cyclooxygenase enzyme and PGE2 expression in patients with functional and non-functional pituitary adenomas

ParameterGroupsPituitary adenoma
(n = 71)
Non-Functional pituitary adenoma
(n = 30)
Functional pituitary adenoma
(n = 41)
Acromegaly
(n = 20)
Cushing
(n = 13)
Prolactinoma
(n = 8)
Age (Years)20–4034(47.88%)13(43.33%)21(51.21%)10(50%)7(53.84%)4(50%)
40–6022(30.98%)9(30%)13(31.70%)6(30%)5(38.46%)2(25%)
60≤15(21.12%)8(26.66%)7(17.07%)4(20%)1(7.69%)2(25%)
GenderFemale34(47.88%)12(40%)22(53.65%)11(55%)8(61.53%)3(37.5%)
Male37(52.11%)18(60%)19(46.34%)9(45%)5(38.46%)5(62.5%)
Tumor invasivenessInvasive33(46.47%)13(43.33%)20(48.78%)10(50%)4(30.76%)6(75%)
Non- Invasive38(53.52%)17(56.66%)21(51.21%)10(50%)9(69.23%)2(25%)
Tumor sizeMicro-Adenoma16(22.53%)016(39.02%)8(40%)8(61.53%)0
Macro-Adenoma55(77.46%)30(100%)25(60.97%)12(60%)5(38.46%)8(100%)